was read the article
array:23 [ "pii" => "S1578219019300460" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.10.023" "estado" => "S300" "fechaPublicacion" => "2019-04-01" "aid" => "2104" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2018" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:181" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 5 "PDF" => 1 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731018305015" "issn" => "00017310" "doi" => "10.1016/j.ad.2018.10.009" "estado" => "S300" "fechaPublicacion" => "2019-04-01" "aid" => "2104" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:181" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 246 "formatos" => array:2 [ "HTML" => 174 "PDF" => 72 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>" "titulo" => "Azatioprina en el tratamiento de la dermatitis atópica grave en pediatría. Experiencia en un hospital de referencia en España" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "181" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Azathioprine in the Treatment of Severe Pediatric Atopic Dermatitis: Experience in a Referral Hospital in Spain" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Vicente Villa" "autores" => array:1 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Vicente Villa" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219019300460" "doi" => "10.1016/j.adengl.2018.10.023" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019300460?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305015?idApp=UINPBA000044" "url" => "/00017310/0000011000000003/v1_201904030618/S0001731018305015/v1_201904030618/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219019300563" "issn" => "15782190" "doi" => "10.1016/j.adengl.2019.02.017" "estado" => "S300" "fechaPublicacion" => "2019-04-01" "aid" => "2131" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Actas Dermosifiliogr. 2019;110:182-92" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 24 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 21 "PDF" => 1 ] ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Adverse Hair Reactions to New Targeted Therapies for Cancer" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:3 [ 0 => "en" 1 => "en" 2 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "182" "paginaFinal" => "192" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Reacciones capilares de las nuevas terapias diana dirigidas contra el cáncer" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0030" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 1085 "Ancho" => 1285 "Tamanyo" => 120868 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.F. Mir-Bonafé, D. Saceda-Corralo, S. Vañó-Galván" "autores" => array:3 [ 0 => array:2 [ "nombre" => "J.F." "apellidos" => "Mir-Bonafé" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Saceda-Corralo" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Vañó-Galván" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0030"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731018305763" "doi" => "10.1016/j.ad.2018.10.019" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305763?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019300563?idApp=UINPBA000044" "url" => "/15782190/0000011000000003/v1_201904030645/S1578219019300563/v1_201904030645/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Azathioprine in the Treatment of Severe Pediatric Atopic Dermatitis: Experience in a Referral Hospital in Spain" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "181" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "A. Vicente Villa" "autores" => array:1 [ 0 => array:3 [ "nombre" => "A." "apellidos" => "Vicente Villa" "email" => array:1 [ 0 => "Avicente@sjdhospitalbarcelona.org" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, España" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Azatioprina en el tratamiento de la dermatitis atópica grave en pediatría. Experiencia en un hospital de referencia en España" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Atopic dermatitis is the most frequent inflammatory skin disease in children and one for which we do not yet have standardized treatment guidelines. Most children and adolescents have mild forms that are controlled with topical treatments. However, in moderate to severe cases that cannot be appropriately managed with topical treatments, other options such as phototherapy or systemic treatment must be considered. None of the classic systemic treatments (ciclosporin, azathioprine, methotrexate, mycophenolate mofetil) include the indication for treatment of atopic dermatitis in children and adolescents in their summary of product characteristics. In addition, there are very few publications on pediatric patients to help us in clinical practice.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In the present issue, Noguera-Morel et al.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">3</span></a> provide a retrospective review of children with severe atopic dermatitis treated with azathioprine over a 10-year period (2007-2017) at Hospital Infantil Universitario Niño Jesús, Madrid, Spain. The retrospective review includes 11 patients with a mean age of 13 years (range, 8-18 years). The authors highlight the effectiveness of the drug with complete or near-complete clearance in 7 of 9 patients at 12-16 weeks of treatment. These findings are somewhat superior to those published elsewhere and similar to those reported for other immunosuppressants. As for safety, only 2 patients had to suspend treatment because of gastrointestinal adverse events.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The authors agree with other specialists that the main drawbacks are the time to response (approximately 3 months) and the need for close monitoring. This publication advocates the use of azathioprine as a systemic treatment option in pediatric patients, albeit not as a first-choice drug.</p><p id="par0020" class="elsevierStylePara elsevierViewall">In the coming years, the advent of new biologics for the treatment of atopic dermatitis in children will show us where classic immunosuppressants stand.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Vicente Villa A. Azatioprina en el tratamiento de la dermatitis atópica grave en pediatría. Experiencia en un hospital de referencia en España. Actas Dermosifiliogr. 2019;110:181.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0020" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral azathioprine for recalcitrant pediatric atopic dermatitis: Clinical response and thiopurine monitoring" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Caufield" 1 => "W.L. Tom" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2012.07.001" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2013" "volumen" => "68" "paginaInicial" => "29" "paginaFinal" => "35" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22892285" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0025" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "N.R. Fuggle" 1 => "W. Bragoli" 2 => "A. Mahto" 3 => "M. Glover" 4 => "A.E. Martinez" 5 => "V.A. Kinsler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2014.08.048" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2015" "volumen" => "72" "paginaInicial" => "108" "paginaFinal" => "114" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25440430" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0030" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estudio retrospectivo del tratamiento sistémico de la dermatitis atópica grave con azatioprina. Eficacia y tolerancia en 11 pacientes pediátricos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L. Noguera-Morel" 1 => "N. Knöpfel" 2 => "A. Torrelo" 3 => "A. Hernández-Martín" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2018" "volumen" => "110" "paginaInicial" => "227" "paginaFinal" => "231" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011000000003/v1_201904030645/S1578219019300460/v1_201904030645/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000003/v1_201904030645/S1578219019300460/v1_201904030645/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019300460?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 7 | 12 |
2024 October | 69 | 41 | 110 |
2024 September | 73 | 16 | 89 |
2024 August | 87 | 44 | 131 |
2024 July | 72 | 43 | 115 |
2024 June | 75 | 40 | 115 |
2024 May | 69 | 25 | 94 |
2024 April | 67 | 27 | 94 |
2024 March | 64 | 28 | 92 |
2024 February | 64 | 28 | 92 |
2024 January | 55 | 31 | 86 |
2023 December | 60 | 15 | 75 |
2023 November | 72 | 22 | 94 |
2023 October | 60 | 20 | 80 |
2023 September | 49 | 27 | 76 |
2023 August | 27 | 11 | 38 |
2023 July | 32 | 36 | 68 |
2023 June | 43 | 23 | 66 |
2023 May | 38 | 23 | 61 |
2023 April | 20 | 18 | 38 |
2023 March | 33 | 21 | 54 |
2023 February | 23 | 16 | 39 |
2023 January | 28 | 12 | 40 |
2022 December | 57 | 33 | 90 |
2022 November | 21 | 30 | 51 |
2022 October | 28 | 12 | 40 |
2022 September | 28 | 36 | 64 |
2022 August | 25 | 26 | 51 |
2022 July | 22 | 33 | 55 |
2022 June | 21 | 29 | 50 |
2022 May | 30 | 31 | 61 |
2022 April | 30 | 34 | 64 |
2022 March | 36 | 56 | 92 |
2022 February | 29 | 25 | 54 |
2022 January | 26 | 34 | 60 |
2021 December | 33 | 34 | 67 |
2021 November | 29 | 39 | 68 |
2021 October | 38 | 43 | 81 |
2021 September | 39 | 39 | 78 |
2021 August | 29 | 26 | 55 |
2021 July | 17 | 17 | 34 |
2021 June | 21 | 20 | 41 |
2021 May | 32 | 33 | 65 |
2021 April | 40 | 45 | 85 |
2021 March | 49 | 24 | 73 |
2021 February | 58 | 13 | 71 |
2021 January | 43 | 12 | 55 |
2020 December | 27 | 10 | 37 |
2020 November | 17 | 19 | 36 |
2020 October | 14 | 7 | 21 |
2020 September | 27 | 7 | 34 |
2020 August | 19 | 22 | 41 |
2020 July | 22 | 16 | 38 |
2020 June | 22 | 22 | 44 |
2020 May | 21 | 8 | 29 |
2020 April | 17 | 7 | 24 |
2020 March | 13 | 7 | 20 |
2020 February | 3 | 0 | 3 |
2019 June | 2 | 0 | 2 |
2019 May | 2 | 0 | 2 |
2019 April | 1 | 1 | 2 |